RND logo.PNG
MicroRNA (miRNA) Market To Reach USD 415.1 Million By 2026 | Reports And Data
May 20, 2019 13:05 ET | Reports And Data
Investments in the development of techniques & tools to overcome existing challenges in clinical translation of microRNA applications, strategic developments such as partnerships and mergers and...
LogoPressRelease.jpg
Sirona Dx Introduces Imaging Mass Cytometry Services to Advance Biomarker Discovery and Therapeutic Development
November 01, 2018 08:30 ET | Fluidigm Corporation
Specialized CRO offers high-definition tissue imaging services for pharmaceutical and clinical research SOUTH SAN FRANCISCO, Calif. and PORTLAND, Ore., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Sirona Dx,...
Logo-BCC-Research.jpg
Global Biomarkers Market to Witness Double-Digit Growth to 2023
September 10, 2018 05:00 ET | BCC Research
WELLESLEY, Mass., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Major drivers for growth of the global biomarkers market include a rise in government grants and research funding, the high prevalence of cancer...
LogoPressRelease.jpg
Fluidigm Announces Second Quarter 2018 Financial Results
August 02, 2018 16:05 ET | Fluidigm Corporation
Total revenue increases 11 percent to $26.4 million Mass cytometry revenue growth of 32 percent Total consumables revenue growth of 19 percent SOUTH SAN FRANCISCO, Calif., Aug. 02, 2018 (GLOBE...
LogoPressRelease.jpg
Fluidigm and Genomenon to Offer Evidence-Based Genomic Panel Design Service
June 07, 2018 07:00 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation announced today that it has entered into a co-marketing agreement with Genomenon to offer evidence-based genomic...
Biodesix_lockup_r_rgb (2).jpg
Biodesix Announces Biomarker Research Collaboration with Checkmate Pharmaceuticals
March 20, 2018 09:00 ET | Biodesix, Inc.
BOULDER, Colo., March 20, 2018 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Boulder, CO, USA), a molecular diagnostics company has entered into a biomarker research collaboration with Checkmate...
Stopping Epilepsy Be
Stopping Epilepsy Before It Starts? CURE Researcher Identifies a Possible Biomarker
February 06, 2018 09:50 ET | About Citizens United for Research in Epilepsy (CURE)
Chicago, Feb. 06, 2018 (GLOBE NEWSWIRE) -- New research, funded by Citizens United for Research in Epilepsy (CURE), has discovered a ‘smoking gun’ biomarker that could result in treatments that stop...
Zivo logo.jpg
ZIVO Bioscience and Tianjin Norland Biotech Execute Letter of Intent to Produce ZIVO Algae Strain in China for International and Domestic Markets
February 01, 2018 07:52 ET | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Feb. 01, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO), a biotech/agtech R&D company engaged in the commercialization of nutritional and medicinal products...
visiongain Logo.png
Visiongain launches report entitled Alzheimer’s disease therapeutics and diagnostics market 2017-2027
January 11, 2018 08:31 ET | Visiongain Ltd
LONDON, Jan. 11, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Disease Therapeutics and Diagnostics Market reached $6.71bn in 2016. The Alzheimer’s Disease Therapeutics and Diagnostics Market is expected...
Zivo logo.jpg
ZIVO Bioscience Subsidiary Wellmetris Selected to Present at Biotech Showcase During JPMorgan Healthcare Conference Jan 7-10 in San Francisco, CA
January 08, 2018 08:00 ET | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO), a biotech/agtech R&D company, announced today that its WellMetris subsidiary will be presenting at...